Log in to your Inderes Free account to see all free content on this page.

Peptonic Medical

Less than 1K followers

Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.

ShowingAll content types

Press release2 hours ago

PEPTONIC Medical AB: Strong Launch of Peptonic Medical's New Product - VagiVital Active Glide

Peptonic Medical

Regulatory press release1/13/2025, 7:20 AM

PEPTONIC Medical AB: The subscription period in Peptonic's rights issue of units starts today

Peptonic Medical

Regulatory press release1/10/2025, 9:20 AM

PEPTONIC Medical AB: Peptonic publishes disclosure document in connection with rights issue of units

Peptonic Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release1/9/2025, 7:00 AM

PEPTONIC Medical AB: Peptonic Medical AB Granted U.S. Patent for Symptomatic Relief of Provoked Vulvodynia in Women

Peptonic Medical

Regulatory press release1/7/2025, 1:10 PM

PEPTONIC Medical AB: Bulletin from the extraordinary general meeting on 7 January 2025 in PEPTONIC medical AB

Peptonic Medical

Regulatory press release11/28/2024, 9:30 PM

PEPTONIC Medical AB: NOTICE OF EXTRAORDINARY GENERAL MEETING IN PEPTONIC MEDICAL AB

Peptonic Medical

Regulatory press release11/28/2024, 9:00 PM

PEPTONIC Medical AB: The board of Peptonic resolves, subject to the approval a subsequent general meeting, on a rights issue of units of approximately SEK 26.5 million

Peptonic Medical

Regulatory press release11/21/2024, 4:30 PM

PEPTONIC Medical AB: Peptonic receives approximately SEK 49.9 thousand through warrants of series TO5

Peptonic Medical

Regulatory press release11/15/2024, 7:30 AM

PEPTONIC Medical AB: Peptonic Medical publishes an operational update

Peptonic Medical

Press release11/15/2024, 7:00 AM

PEPTONIC Medical AB: The last day of trading with the warrants of series TO5 in PEPTONIC medical AB is today, November 15, 2024

Peptonic Medical

Regulatory press release11/12/2024, 6:30 PM

PEPTONIC Medical AB: Peptonic Medical AB closes its Israeli subsidiary

Peptonic Medical

Regulatory press release11/6/2024, 7:55 AM

PEPTONIC Medical AB: The exercise period for subscription of shares through exercise of warrants of series TO5 begins today

Peptonic Medical

Press release11/5/2024, 7:00 AM

PEPTONIC Medical AB: Peptonic Medical strengthens U.S. market presence with full-scale launch of VagiVital

Peptonic Medical

Regulatory press release7/8/2024, 4:00 PM

PEPTONIC Medical AB: Peptonic announces the last day of trading in BTU and the first day of trading in warrants of series TO 5

Peptonic Medical

Press release7/3/2024, 6:00 AM

PEPTONIC Medical AB: Peptonic Medical AB Granted Patent in Australia: Vernivia Secures Exclusivity Until 2038

Peptonic Medical

Regulatory press release6/14/2024, 8:15 AM

PEPTONIC Medical AB: Peptonic announces outcome in the rights issue and the directed issue

Peptonic Medical

Regulatory press release6/11/2024, 6:00 AM

PEPTONIC Medical AB: Peptonic Medical provides an operational update after the first 120 days with new CEO

Peptonic Medical

Regulatory press release6/7/2024, 6:00 AM

PEPTONIC Medical AB: Last day of trading with the unit rights in Peptonic

Peptonic Medical

Regulatory press release5/31/2024, 8:00 AM

PEPTONIC Medical AB: Peptonic Medical AB granted patent in Europe for relief of provoked vulvodynia in women. Product ready for launch.

Peptonic Medical

Regulatory press release5/28/2024, 6:30 AM

PEPTONIC Medical AB: The subscription period in Peptonic's rights issue of units starts today

Peptonic Medical

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.